Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:21 pm Unchanged |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Ares Trading S.A. | 1,913,501 3.600% |
0 (Unchanged) |
Filing History |
| 2024-02-14 3:20 pm Unchanged |
2023-12-31 | 13G | INTREXON CORP XON |
Ares Trading S.A. | 20,647,152 8.300% |
0 (Unchanged) |
Filing History |
| 2023-01-27 09:29 am Unchanged |
2022-12-31 | 13G | INTREXON CORP XON |
Ares Trading S.A. | 20,647,152 9.920% |
0 (Unchanged) |
Filing History |
| 2023-01-27 06:17 am Unchanged |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Ares Trading S.A. | 1,913,501 6.920% |
0 (Unchanged) |
Filing History |
| 2022-01-24 10:04 am Sale |
2021-12-31 | 13G | INTREXON CORP XON |
Ares Trading S.A. | 20,647,152 9.990% |
-6,751,367 (-24.64%) |
Filing History |
| 2022-01-24 10:01 am Purchase |
2021-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Ares Trading S.A. | 1,913,501 8.990% |
1,913,501 (New Position) |
Filing History |
| 2021-01-08 11:52 am Purchase |
2020-12-31 | 13G | INTREXON CORP XON |
Ares Trading S.A. | 27,398,519 14.800% |
2,546,171 (+10.25%) |
Filing History |